Supernus Pharmaceuticals Inc - fluxo de caixa trimestral (NASDAQ:SUPN)

Financials

Cash from operating activities 44.41 M30.6 M58.53 M-61.66 M19.86 M 47.33 M Cash from investing activities -12.64 M37.32 M-30.61 M48.71 M-51.31 M 4.11 M Cash from financing activities 5.89 M-21.4 M935 K21.07 M8.53 M 9.13 M Free cash flow 44.19 M30.27 M58.08 M-61.79 M19.43 M 45.99 M

Notícias

Jefferies reitera recomendação de compra para ações da Supernus Pharmaceuticals

Supernus na conferência da Barclays: crescimento estratégico e perspectivas futuras

Supernus at Barclays Conference: Strategic Growth and Future Prospects

Supernus na Conferência TD Cowen: diversificação estratégica revelada

Supernus at TD Cowen Conference: Strategic Diversification Unveiled

TD Cowen eleva preço-alvo da Supernus Pharmaceuticals com relançamento da Onapgo

TD Cowen raises Supernus Pharmaceuticals stock price target on Onapgo relaunch

Ações da Supernus Pharmaceuticals atingem máxima de 52 semanas a US$ 57,76

Supernus Pharmaceuticals stock hits 52-week high at $57.76

Cantor Fitzgerald reitera classificação acima da média para Supernus com ganhos de fornecimento

Cantor Fitzgerald reiterates Supernus stock Overweight on supply gains

Supernus (SUPN) Reports Q4 Earnings: What Key Metrics Have to Say